Hyperbaric Oxygen therapy is recommended as an adjuvant therapy for diabetic neuropathy.
Hyperbaric oxygen
therapy (HBO) involves breathing pure oxygen at higher than atmospheric pressures
in an enclosed chamber. This research article revealed the
importance of hyperbaric oxygen therapy for diabetic olfactory neuropathies. In
this therapy, pure oxygen is breathed in a pressurized room or tube to provide
adequate supply of oxygen to function in the tissues of body.
Hyperbaric Oxygen
therapy is recommended as an adjuvant therapy for diabetic neuropathy. To
investigate olfactory dysfunction and show the effectiveness of hyperbaric
oxygen treatment in patients with type 2 diabetic neuropathy.
Patients
diagnosed with Type 2 DM and diabetic neuropathy were included in the group 1.
Patients of Group 1 were administered with a hyperbaric oxygen therapy for 30
sessions and patients who returned for a checkup following 30 sessions were
incorporated into the Group 2. Healthy volunteers with no medical problems were
included in the study as a control group (Group 3). Connecticut Chemosensory
Clinical Research (CCCRC) test and the subjective visual analog scale (VAS;
0-100) were utilized to evaluate the olfactory function.
There was a
statistically significant difference both between the control group and the
patient group as well as before and after the HBO therapy in terms of total
CCCRC scoring averages and VAS Scoring averages.
When compared to
normal individuals, type 2 diabetic neuropathy can cause an olfactory
dysfunction, and a statistically significant improvement in olfaction can be
obtained with HBO therapy. This is the first study demonstrating that the HBO
therapy can play a role in treating olfactory dysfunctions suffered by the
patients with diabetic olfactory neuropathies.
Rhinology
Hyperbaric oxygen therapy of olfactory dysfunction in diabetic neuropathy with type 2 diabetes mellitus and a new definition Diabetic Olfactopathy
B. Veyseller et al.
Comments (0)